Literature DB >> 17233641

Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.

R S Reiserer1, F E Harrison, D C Syverud, M P McDonald.   

Abstract

Mice co-expressing the Swedish amyloid precursor protein mutation (APP(Swe)) and exon 9 deletion (DeltaE9) of the PSEN1 gene begin to develop amyloid plaques at 6-7 months of age. We demonstrate here a spatial learning deficit in 7-month-old APP(Swe) + PSEN1DeltaE9 bigenic mice using an adaptation of the Barnes maze. Mice were first trained on a cued target followed by a hidden-target condition. Although bigenic mice quickly learned the cued-target version of the task, they were significantly impaired when switched to the hidden-target version. In contrast, a separate group of double-transgenic mice trained first on the spatial hidden-target version of the task were unimpaired relative to wild-type controls. We propose that processes such as general rule learning, context learning and exploratory habituation exert a greater influence when the testing environment is novel and overshadow the spatial memory deficit in naive bigenic mice. However, when cued-target training is conducted first, these processes habituate and the spatial learning deficit is unmasked. Seven-month-old APP(Swe) + PSEN1DeltaE9 mice were unimpaired on tests of memory that did not involve learning the rules governing spatial associations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17233641     DOI: 10.1111/j.1601-183X.2006.00221.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  132 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis.

Authors:  Karienn S Montgomery; George Edwards; Yona Levites; Ashok Kumar; Catherine E Myers; Mark A Gluck; Barry Setlow; Jennifer L Bizon
Journal:  Hippocampus       Date:  2015-10-19       Impact factor: 3.899

3.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

4.  Spatial and nonspatial escape strategies in the Barnes maze.

Authors:  Fiona E Harrison; Randall S Reiserer; Andrew J Tomarken; Michael P McDonald
Journal:  Learn Mem       Date:  2006-11-13       Impact factor: 2.460

5.  Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.

Authors:  Salim S El-Amouri; Hong Zhu; Jin Yu; Robert Marr; Inder M Verma; Mark S Kindy
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

6.  Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics.

Authors:  T J Flanigan; Y Xue; S Kishan Rao; A Dhanushkodi; M P McDonald
Journal:  Genes Brain Behav       Date:  2014-04-22       Impact factor: 3.449

Review 7.  Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.

Authors:  A Shepherd; S Tyebji; A J Hannan; E L Burrows
Journal:  J Mol Neurosci       Date:  2016-09-16       Impact factor: 3.444

8.  Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Authors:  Ehud Cohen; Johan F Paulsson; Pablo Blinder; Tal Burstyn-Cohen; Deguo Du; Gabriela Estepa; Anthony Adame; Hang M Pham; Martin Holzenberger; Jeffery W Kelly; Eliezer Masliah; Andrew Dillin
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

9.  Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks.

Authors:  F E Harrison; A H Hosseini; M P McDonald
Journal:  Behav Brain Res       Date:  2008-10-18       Impact factor: 3.332

10.  Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance.

Authors:  Xiao-Dan Guo; Guang-Long Sun; Ting-Ting Zhou; Xin Xu; Zhi-Yuan Zhu; Vatcharin Rukachaisirikul; Li-Hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.